The Patent Finder

Supratek Pharma Inc.

Also on record
Records under this name other than patents Supratek Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Supratek Pharma Inc.

PatentTitleStatus Expires Confidence
US 8,703,964Bendamustine cyclopolysaccharide compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,389,558Bendamustine amphiphilic anionic compositions
Formerly held
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
US 8,436,032Bendamustine cyclopolysaccharide compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,383,663Bendamustine anionic-catioinic cyclopolysaccharide compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,919,053Cabazitaxel composition
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,148,338Doxorubicin formulations for anti-cancer use
Formerly held
Lapsed on the fee record
Ended Apr 3, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 3, 2024From the USPTO record
US 6,277,410Copolymer compositions for oral delivery
Term ended
Term ended Feb 6, 2018 · From the USPTO record
Term endedTerm ended Feb 6, 2018From the USPTO record
US 6,440,743Methods of using polynucleotide compositions
Lapsed on the fee record
Ended Aug 27, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 27, 2014From the USPTO record
US 7,772,255Method of treating tumors with azaxanthones
Lapsed on the fee record
Ended Aug 10, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 10, 2014From the USPTO record
US 6,359,054Polynucleotide compositions for intramuscular administration
Lapsed on the fee record
Ended Mar 19, 2014 · From the USPTO record
Lapsed on the fee recordEnded Mar 19, 2014From the USPTO record
10 of 31 patents shown.
Pro members see all 31.
Pro members: see all 31 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited